Home LiteratureArticle Details
PMID: 437366 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Downregulation of insulin receptors in obese man.

Diabetes ·Vol. 28 ·No. 4 ·1979-04-00 ·Pages 287-91

Wigand JP, Blackard WG

Abstract

In an attempt to determine whether the decreased number of insulin's receptors in obesity is a result of downregulation of the receptors, diazoxide (5 mg/kg/d) was given to 10 obese subjects. Insulin's suppression by diazoxide in these 10 subjects resulted in a mild glucose intolerance and an increase in insulin's receptors in seven of the 10 subjects. The subjects could be divided into three groups by analyzing the Scatchard plots of their insulin receptor studies before and after diazoxide. Four subjects exhibited an increase in both high affinity and low affinity receptors, three showed an increase only in high affinity receptors, and three failed to demonstrate any change in receptors in response to diazoxide. These studies support the concept that the decreased number of insulin's receptors observed in obesity is a result of the downregulation of the receptors and is not the primary, underlying cause of insulin resistance in obesity, although a contributory role cannot be ruled out.

MeSH Terms
Adolescent Adult Diazoxide Glucose Tolerance Test Humans Insulin/metabolism Kinetics Male Monocytes/drug effects,metabolism Obesity/metabolism Receptor, Insulin/drug effects,metabolism
Chemicals
Insulin Receptor, Insulin Diazoxide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wigand J P
Blackard W G
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1979-04-00
Pages
287-91
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com